In order to maximise the benefits of treatment for HIV or viral hepatitis, it is critical to test and diagnose people as soon as possible in the course of the infection. ECDC supports this objective of European Testing Week.
The Carnival season will last from 1 to 9 March 2019. In Rio de Janeiro, Brazil, 1 million participants are expected, including many travellers from Europe
On European Antibiotic Awareness Day, ECDC publishes the results of two point-prevalence surveys of healthcare-associated infections and antimicrobial use in hospitals and in long-term care facilities in the EU/EEA.
On the occasion of World Hepatitis Day, ECDC launched online prevalence database for hepatitis B and C which included data mainly based on peer-reviewed cross sectional studies from 2006 onwards.
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.
In their joint public health Guidance published today, ECDC and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), present the evidence on active case finding as a key measure to diagnose communicable diseases early.
The main objective of the course was to strengthen capacity in EU Member States for control of healthcare-associated infections due to multidrug-resistant organisms (MDROs) in acute health care settings and to promote the broadest possible implementation of appropriate methods.